Feature

Two cups of coffee increase heart dangers with hypertension


 

FROM JOURNAL OF AMERICAN HEART ASSOCIATION

Drinking two or more cups of coffee a day was associated with twice the risk of death from cardiovascular disease among people with severe hypertension, according to researchers at Institute for Global Health Policy Research, Bureau of International Health Cooperation, National Center for Global Health and Medicine, Tokyo.

What to know

People with severely high blood pressure who drink two or more cups of caffeinated coffee each day could double their risk of dying from a heart attack, stroke, or any type of cardiovascular disease.

Too much coffee may raise blood pressure and lead to anxiety, heart palpitations, and difficulty sleeping.

An 8-ounce cup of coffee has 80-100 mg of caffeine, while an 8-ounce cup of green or black tea has 30-50 mg.

Drinking one cup of coffee a day or any amount of green tea was not associated with risk of death across any blood pressure categories, and drinking green tea was not associated with increased risk of death related to cardiovascular disease at any blood pressure level.

Frequent consumers of coffee were more likely to be younger, current smokers, current drinkers, to eat fewer vegetables, and to have higher total cholesterol levels and lower systolic blood pressure regardless of their blood pressure category.

This is a summary of the article “Coffee and Green Tea Consumption and Cardiovascular Disease Mortality Among People With and Without Hypertension,” published in the Journal of the American Heart Association.

A version of this article first appeared on Medscape.com.

Recommended Reading

Is preeclampsia a cardiovascular time bomb for mothers?
MDedge Cardiology
Angioedema risk jumps when switching HF meds
MDedge Cardiology
CV deaths jumped in 2020, reflecting pandemic toll
MDedge Cardiology
The new blood pressure target in primary care
MDedge Cardiology
Frequent visits to green spaces linked to lower use of some meds
MDedge Cardiology
Longer diabetes duration links with increased heart failure
MDedge Cardiology
Persistent gaps in drug use by patients with type 2 diabetes
MDedge Cardiology
Cardiac monitoring company settles DOJ false claims allegations
MDedge Cardiology
Dapagliflozin gets expanded heart failure indication in Europe
MDedge Cardiology
USPSTF backs screening for hypertensive disorders of pregnancy
MDedge Cardiology